Literature DB >> 19527396

High uterosacral ligament vault suspension at vaginal hysterectomy: objective and subjective outcomes of a modified technique.

Stephen T Jeffery1, Stergios K Doumouchtsis, Anna V M Franco, Michelle M Fynes.   

Abstract

AIMS: To evaluate the outcomes of a modified high uterosacral ligament suspension (HUSLS) performed at vaginal hysterectomy for uterine prolapse.
METHODS: Prolapse was assessed pre- and postoperatively in 53 consecutive women, using Baden-Walker Halfway and Pelvic Organ Prolapse Quantification systems. Sexually active women completed the Prolapse and Incontinence Sexual Function Questionnaire at follow up. The technique involves placement of one HUSLS suture on each side without a fascial reconstruction.
RESULTS: Preoperatively, 37 (66%) women had at least Grade 2 prolapse of the cervix. At mean follow-up of 15 months, 45 (85%) had no vault prolapse and 7 (13%) had Grade 1 prolapse. Nineteen (36%) women were sexually active at follow up and completed the Prolapse and Incontinence Sexual Function Questionnaire. Mean scores for pain, vaginal tightness, partner perception of tightness and vaginal length were 2.8, 3.2, 4.0, and 3.8 respectively, indicating excellent function.
CONCLUSIONS: We report excellent objective, subjective and sexual function outcomes following this modified HUSLS.

Entities:  

Mesh:

Year:  2009        PMID: 19527396     DOI: 10.1111/j.1447-0756.2008.00984.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  2 in total

1.  Laparoscopic high uterosacral ligament suspension: an alternative route for a traditional technique.

Authors:  Giovanni Panico; Giuseppe Campagna; Daniela Caramazza; Nicola Amato; Alfredo Ercoli; Giovanni Scambia; Mauro Cervigni; Riccardo Zaccoletti
Journal:  Int Urogynecol J       Date:  2018-03-02       Impact factor: 2.894

2.  Long-term outcomes of modified high uterosacral ligament vault suspension (HUSLS) at vaginal hysterectomy.

Authors:  Stergios K Doumouchtsis; Azar Khunda; Stephen T Jeffery; Anna Virginia M Franco; Michelle M Fynes
Journal:  Int Urogynecol J       Date:  2010-12-02       Impact factor: 2.894

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.